Quantcast

New Study Links Blood Clot Risk to NuvaRing

May 17, 2012

According to the study published on May 10th 2012 in the British Medical Journal, non-oral contraceptives, including NuvaRing, have a higher risk of blood clots than combined oral contraceptives (COCs) based on oestrogens and progestins. NuvaRing, approved by the FDA in 2001, is a contraceptive that comes in the form of a vaginal ring using female hormones in an effort to prevent ovulation. Women who used a vaginal ring had a 6.5 times higher risk for developing blood clots compared to non-users of hormonal contraception. As of Dec. 31st 2011, approximately 950 lawsuits were pending, alleging injuries sustained from NuvaRing use, including some alleged deaths, heart attacks and strokes. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of NuvaRing severe adverse events. [http://www.attorneyone.com/nuva-ring/ .

San Diego, CA (PRWEB) May 17, 2012

The media spotlight is often a double-edged sword. No one knows this better than women who suffer from Nuva Ring severe adverse events. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

According to the study published on May 10th 2012 in the British Medical Journal, non-oral contraceptives, including NuvaRing, have a higher risk of blood clots than combined oral contraceptives (COCs) based on oestrogens and progestins. NuvaRing, approved by the FDA in 2001, is a contraceptive that comes in the form of a vaginal ring using female hormones in an effort to prevent ovulation. Women who used a vaginal ring had a 6.5 times higher risk for developing blood clots compared to non-users of hormonal contraception. The team conducting the study collected data on incidents of venous thrombosis in Danish women, aged 15-49, using methods of birth control other than the pill.

As of Dec. 31st 2011, approximately 950 NuvaRing lawsuits were pending alleging injuries sustained from NuvaRing use, including some alleged deaths, heart attacks and strokes. NuvaRing is marketed and sold by subsidiaries of Merck, Organon USA Inc. and Schering-Plough.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of NuvaRing severe adverse events, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from NuvaRing remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

In October 2011, the FDA released a study revealing that NuvaRing raised the risk of blood clots, including DVT and PE by 56% when compared to older birth control pills.

AttorneyOne.com has further information on NuvaRing lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about NuvaRing at our website. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/5/prweb9502438.htm.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/5/prweb9512079.htm


Source: prweb



comments powered by Disqus